Skip to search formSkip to main contentSkip to account menu

Proresid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Summary“Proresid” (podophyllic acid ethylhydrazide; SP-1, Sandoz), a cytostatic drug with rapid but reversible effects on mitosis… 
1995
1995
The cancer risk was studied by comparison of 305 rheumatoid arthritis (RA) patients exposed to Proresid during a mean time of 22… 
1993
1993
Proresid, mainly consisting of podophyllotoxin derivatives and two glycosides thereof, has been used as a disease-modifying… 
1993
1993
A mixture of natural and semisynthetic (modified) glycosides from Podophyllum emodi (Proresid) has been used for many years in… 
1989
1989
  • A. Larsen
  • Scandinavian journal of rheumatology
  • 1989
  • Corpus ID: 39770792
1988
1988
Drug withdrawal rate and reasons for treatment termination were studied in a retrospective life-table analysis of patients with… 
1988
1988
Proresid-Sandoz (P), a microtubulin antagonist comparable to colchicine and griseofulvin, has antimitotic properties (1). It has… 
1976
1976
90 out of 191 patients with bronchial carcinomas were treated exclusively with telecobalt (focal dose ofer 4,500 rad), 78… 
1973
1973
"Proresid" (podophyllic acid ethylhydrazide; SP-1, Sandoz), a cytostatic drug with rapid but reversible effects on mitosis… 
Review
1971
Review
1971
  • F. Bettley
  • The British journal of dermatology
  • 1971
  • Corpus ID: 1563896
SUMMARY.— The local chemotherapy of cutaneous carcinoma with 5‐fluorouracil, methotrexate and colcemide is reviewed.